Praxis Pharmaceutical, S.A.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Praxis Pharmaceutical, S.A.
Allergan has tried to go after alopecia in the past; Exicure brings a new spherical nucleic acid (SNA) technology. In other recent deals, AstraZeneca sells Seroquel, Losec rights to Germany’s Cheplapharm.
Acumen Pharmaceuticals completed the first closing a $20 million Series A funding round, which will be used to demonstrate proof of concept for the monoclonal antibody ACU-193 in the treatment of Alzheimer's disease by 2016.
As the budget of Estonia's health insurance fund, the Haigekassa, is to be cut by 6% next year, patient fees for hospital stays are to be increased to Eek100 ($9.40) per day from the beginning of next year. At present, they are Eek25 per day during the first 10 days in hospital, and children and teenagers under 19 years of age, pregnant women and patients in intensive care wards are exempt.
- Contract Manufacturing Organization
- Other Names / Subsidiaries
- PRX Pharma Produtos Farmacêuticos Unipessoal, LDA